Masaka, Uganda | THE INDEPENDENT | Researchers are studying the effectiveness of a daily Pre-Exposure Prophylaxis (PrEP) drug Descovy in their HIV vaccine study that was launched recently in Masaka district. Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network …
Read More »Researchers embark on another PrEP study
Kampala, Uganda | THE INDEPENDENT | Researchers at Makerere University – John Hopkins Research Collaboration (MU-JHU) are embarking on a new study to establish the effectiveness of using the new HIV drug, Islatravir in HIV prevention as a Pre-exposure Prophylaxis (PrEP). Dr Gatti Brenda Mirembe, the principal investigator on the study …
Read More »Uganda embarks on new HIV-PrEP study
Kampala, Uganda | THE INDEPENDENT | A new HIV Pre-exposure Prophylaxis (PrEP) study is underway to establish whether a six months-long injectable drug, Lenacapavir (LEN), and oral drug Descovy can protect HIV negative women and girls from acquiring the virus. The two-part study is being done by a team of researchers …
Read More »Uganda listed among first countries to benefit from vaginal ring rollout
Kampala, Uganda | THE INDEPENDENT | Uganda has been listed among the first seven countries that will benefit from the roll out of the vaginal ring used in prevention against HIV, the International Partnership for Microbicides (IPM) has revealed. IPM’s external relations director Dr. Leonard Solai told journalists that other …
Read More »Cabotegravir found effective in offering protection against HIV
Kampala, Uganda | THE INDEPENDENT | Injectable HIV drug cabotegravir has been found effective in offering protection against the disease if taken by HIV negative person as a form of Pre-Exposure Prophylaxis (PrEP). In a large scale study code-named HPTN 083 that has been halted because of the coronavirus pandemic, a …
Read More »UVRI to conduct new HIV vaccine trial in May
Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute will in May conduct a new HIV vaccine trial. Prof. Pontiano Kaleebu the Executive director of Uganda Virus Research Institute (UVRI), says that the participants will be given Pre-exposure Prophylaxis (PrEP) drugs to guard them against possible infection during …
Read More »White Americans far likelier to receive HIV prevention drug than minorities
Washington, United States | AFP | White Americans who are at risk of HIV are seven times more likely than blacks to receive a daily oral pill shown to be extremely effective at preventing infection, according to official statistics published Tuesday. The figures released by the Centers for Disease Control and Prevention (CDC) underscore that …
Read More »Uganda will not dispense PrEP over the counter- Minister
Kampala, Uganda | THE INDEPENDENT | As HIV activists around the world are pushing for Pre-exposure Prophylaxis (PrEP) and Post Exposure Prophylaxis (PEP) to be accessed over the counter, the health ministry says that it will not be considered in Uganda. In an interview with Uganda Radio Network on Thursday, …
Read More »Popular birth control shot does not increase HIV risk – Study
Kampala, Uganda | THE INDEPENDENT | Healthcare managers have been urged to invest more in woman-centred programs that offer a full range of contraceptive choices concurrently with HIV prevention strategies. The call was made by Dr Brenda Mirembe Gatti, an HIV Researcher based at the Makerere University John Hopkins University …
Read More »HIV and young girls
New study starts on choice in prevention methods Kampala, Uganda | FLAVIA NASSAKA | Something unusual is happening at the Makerere University – John Hopkins University (MUJHU) research collaboration facility at Mulago hill in Kampala. The walls of the aging building have been freshly painted white with carefully coated patches …
Read More »
The Independent Uganda: You get the Truth we Pay the Price